In a landmark development for the field of condensed matter physics, a collaborative team of scientists from McGill University, the…
Read More

In a landmark development for the field of condensed matter physics, a collaborative team of scientists from McGill University, the…
Read More
In a significant advancement for quantum information science, researchers at the University of Chicago Pritzker School of Molecular Engineering (PME)…
Read More
A collaborative study led by researchers from Monash University, the University of São Paulo, and Deakin University has revealed that…
Read More
Developing treatments for ultra-rare diseases presents fundamental challenges for traditional evidence generation, necessitating a paradigm shift in how scientific rigor…
Read More
The U.S. Food and Drug Administration (FDA) has recently issued a significant approval for AbbVie’s antibody-drug conjugate (ADC) targeting blastic…
Read More
The quest to miniaturize photonic devices to the scale of modern electronic circuits has long been stymied by the fundamental…
Read More
Developing treatments for the approximately 7,000 known rare diseases, particularly the subset classified as ultra-rare, presents profound and often insurmountable…
Read More
The pursuit of clean, limitless energy through nuclear fusion and the understanding of the most violent phenomena in the universe…
Read More
The landscape of drug development for ultra-rare diseases is undergoing a significant transformation, driven by the U.S. Food and Drug…
Read More
The research, spearheaded by Professor Mingxin Huang, marks a pivotal moment in materials science. By utilizing a "sequential dual-passivation" strategy,…
Read More